Part of the DODS Group DODS Group Logo
Menu
Fri, 30 September 2022

Newsletter sign-up

Subscribe now
Search

Follow us:

Articles tagged with: medicines
LifeArc Joins Forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to Strengthen Antimicrobial Discovery Efforts Partner content
Health
By Medicines Discovery Catapult
LifeArc Joins Forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to Strengthen Antimicrobial Discovery Efforts
Pivotal partnership seeks to transform Cystic Fibrosis research.
World Patient Safety Day- Why the UK must do more to tackle medication errors Partner content
Health
By BD
World Patient Safety Day- Why the UK must do more to tackle medication errors
Every person will at some point in their life, take medications to prevent or treat illness. Medication is a fundamental part of our healthcare system, however, it has the potential to cause serious harm, sometimes even death if incorrectly stored, prescribed, dispensed, administered or if monitored insufficiently.
Partner content
Health
By Medicines Discovery Catapult
Global Expansion: Psychiatry Consortium Welcomes New International Partner
Medicines Discovery Catapult Welcome Shionogi to the Psychiatry Consortium.
Medicines Discovery Catapult and ZEISS Set Sights on Advancing Microscopy Partner content
Health
By Medicines Discovery Catapult
Medicines Discovery Catapult and ZEISS Set Sights on Advancing Microscopy
Medicines Discovery Catapult and ZEISS have announced a new partnership to drive the application of microscopy in drug discovery.
Why Portsmouth needs a medical school Partner content
Health
By University of Portsmouth
Why Portsmouth needs a medical school
A medical school at the University of Portsmouth could help transform the city’s GP provision.
Medicines Discovery Catapult Supports Cystic Fibrosis Week 2022 Partner content
Health
By Medicines Discovery Catapult
Medicines Discovery Catapult Supports Cystic Fibrosis Week 2022
Exploring the theme of ‘lifting the limits together’, this week (13-19 June) marks Cystic Fibrosis (CF) Week 2022. The event is a week-long opportunity to celebrate the courage and resilience shown by the CF community, whilst raising awareness and demystifying misconceptions surrounding the disease.
We must act now to unlock the potential that gene therapies could offer people with rare diseases Partner content
Health
By Pfizer UK
We must act now to unlock the potential that gene therapies could offer people with rare diseases
The formation of a Gene Therapy Taskforce could help ensure people with genetic rare diseases can access the latest scientific advances.
By investing in the right treatment and after-care for stroke survivors, we could improve patient outcomes and save the NHS money
Health
By Sir Robert Neill MP
By investing in the right treatment and after-care for stroke survivors, we could improve patient outcomes and save the NHS money
To begin with, an admission: prior to summer 2019 my knowledge of stroke, like many, was somewhat limited.
Partner content
Health
By Medicines Discovery Catapult
Medicine Discovery Catapult’s Psychiatry Consortium announces new international collaboration to tackle depression
The University of Trento and the University of Bologna are collaborating with global pharmaceutical companies including, Biogen Inc, Janssen Pharmaceutica NV and Merck Sharp and Dohme Corp. in a new Psychiatry Consortium project that will seek to define a new pharmacological approach to treat depression.
We must learn from Covid to avert an antibiotic resistance pandemic
Health
By Kevin Hollinrake MP
We must learn from Covid to avert an antibiotic resistance pandemic
Unlike Coronavirus, we have a chance to solve antibiotic resistance before it spirals out of control.
Partner content
Environment
By NOAH
Animal health industry associations warn solutions are needed to address Northern Ireland Protocol veterinary medicines supply concerns
NOAH, along with AnimalhealthEurope, is concerned that the Northern Ireland Protocol (NIP) introduced following the UK’s exit from the EU could, in its current format, cause substantial disruption to veterinary medicines supply. In exchanges with the authorities, the associations have put forward solutions to avoid these supply issues, and the consequent negative impact on animal health and welfare they would cause.
How can we implement effective strategies to alleviate and support long-COVID? Partner content
Health
By British Association for Nutrition and Lifestyle Medicine (BANT)
How can we implement effective strategies to alleviate and support long-COVID?
With the so-called curse of “Long-COVID” estimated to affect a third of people post-infection, the legacy of this virus is set to disrupt populations for years to come. It is still unclear as to why some people experience the virus more, or less, severely, and why prolonged symptoms linger in some but not in others.
We must unlock the full potential of cell and gene therapies
Health
By Daniel Zeichner MP
We must unlock the full potential of cell and gene therapies
In July, I was delighted to chair a Policy Connect roundtable on cell and gene therapies, to consider how they can contribute to better patient care, the wider health service and the economy.
Partner content
Environment
By NOAH
NOAH/Lantra Animal Medicines Best Practice (AMBP) farmer training delivers solution to meet new Red Tractor requirements
To ensure global medical advances, we must collaborate across geopolitical divides
Health
By Lord St John
To ensure global medical advances, we must collaborate across geopolitical divides
At every stage of our response to Covid-19, genomic science has powered our understanding, from developing quick at-home tests to tracking and containing variants.
Partner content
Health
By Medicines Discovery Catapult
Medicines Discovery Catapult and We Share Ventures collaborate in novel funding partnership to drive medicines discovery in areas of unmet patient need
Medicines Discovery Catapult (MDC) and We Share Ventures have embarked on a joint venture, piloting an innovative funding model aimed at opening new funding opportunities for early-stage medicines discovery.
Partner content
Health
By Medicines Discovery Catapult
Medicines Discovery Catapult relaunches Wolfson Radiochemistry facility in Manchester
Medicines Discovery Catapult (MDC) today announces the relaunch of radiochemistry at the Wolfson Molecular Imaging Centre (WMIC) in Manchester.
Partner content
Health
By Medicines Discovery Catapult
Medicines Discovery Catapult welcomes new scientific and people leaders
Partner content
Health
By Medicines Discovery Catapult
No code, no problem: Chief.AI and Medicines Discovery Catapult harness the power of AI for new pay as you go drug discovery platform
Medical nutrition is a vital cog in the NHS response to Covid-19 Partner content
Coronavirus
By British Specialist Nutrition Association (BSNA)
Medical nutrition is a vital cog in the NHS response to Covid-19
It is now over a year since the first cases of patients with COVID-19 were admitted to hospital in the UK, and following huge innovation and improvements in the treatments on offer, and the successful take up of vaccinations across all age groups, the link between cases and hospitalisation looks close to being broken.
Government must intervene as the UK’s medical cannabis crisis reaches breaking point
Health
By Alberto Costa MP
Government must intervene as the UK’s medical cannabis crisis reaches breaking point
Government must urgently establish an emergency compassionate access fund so that families can continue to access medical cannabis through the NHS.
Partner content
Health
By British Association for Nutrition and Lifestyle Medicine (BANT)
BANT welcomes the BJGP article on the ‘lifestyle medicine movement’ and opens the door to further discussions.
BANT welcomes the British Journal of General Practice (BJGP) May 4th article on lifestyle medicine and is encouraged by the acknowledgement of well-informed drivers validating this movement.
WATCH: How can we ensure patients access innovative medicines quickly? Partner content
Coronavirus
By AbbVie
WATCH: How can we ensure patients access innovative medicines quickly?
What can the UK Government and others do to ensure the system keeps pace with scientific developments, helping patients overcome delays in accessing innovative new medicines?
Partner content
Health
By Medicines Discovery Catapult
Investigating new treatment for schizophrenia as first Psychiatry Consortium funded project announced
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.